Background: Ets transcription factors have been widely implicated in the control of tumorigenesis, with most studies suggesting tumor-promoting roles. However, few studies have examined Ets tumorigenesis-modifying functions in vivo using model genetic systems. Methods: Using mice expressing a previously characterized Ets dominant repressor transgene in the intestinal epithelium (Villin-En/Erm), we examined the consequences of blocking endogenous Ets-mediated transcriptional activation on tumorigenesis in the ApcMin model of intestinal carcinoma. Results: En/Erm expression in the intestine, at levels not associated with overt crypt-villus dysmorphogenesis, results in a marked increase in tumor number in ApcMin animals. Moreover, when examined histologically, tumors from En/Erm-expressing animals show a trend toward greater stromal invasiveness. Detailed analysis of crypt-villus homeostasis in these En/Erm transgenic animals suggests increased epithelial turnover as one possible mechanism for the enhanced tumorigenesis. Conclusion: Our findings provide in vivo evidence for a tumor-restricting function of endogenous Ets factors in the intestinal epithelium. © 2009 Jedlicka et al; licensee BioMed Central Ltd.
CITATION STYLE
Jedlicka, P., Sui, X., & Gutierrez-Hartmann, A. (2009). The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer, 9. https://doi.org/10.1186/1471-2407-9-197
Mendeley helps you to discover research relevant for your work.